Melinda Smith
Psychiatric/Mental Health · Saint Louis, MONPI 1831446863
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 464 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 18.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $5,959, more than ten times the $122 reported in 2021. Among psychiatric/mental health clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 464 payments — averaging $27.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Teva Pharmaceuticals USA, Inc.$2K
- Alkermes, Inc.$2K
- Otsuka America Pharmaceutical, Inc.$1K
- E.r. Squibb & Sons, L.L.C.$1K
- Neurocrine Biosciences, Inc.$927
- plus $3K from 13 others
What the payments were for
- Food & beverage$12,57499%
- Education$1721%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 91 | $2,402 |
| Teva Pharmaceuticals USA, Inc. | 79 | $1,999 |
| Alkermes, Inc. | 65 | $1,668 |
| Otsuka America Pharmaceutical, Inc. | 47 | $1,238 |
| E.r. Squibb & Sons, L.L.C. | 39 | $1,192 |
| Neurocrine Biosciences, Inc. | 39 | $927 |
| AbbVie | 17 | $726 |
| Vanda Pharmaceuticals Inc. | 14 | $572 |
| Johnson & Johnson | 19 | $545 |
| Lundbeck LLC | 30 | $420 |
| Luye Pharma (USA) Ltd. | 6 | $328 |
| Axsome Therapeutics, Inc. | 5 | $287 |
| Indivior Inc. | 5 | $122 |
| Biogen | 1 | $117 |
| La Jolla Pharmaceutical Company | 1 | $113 |
| Noven Therapeutics, LLC | 3 | $38 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $20 |
| Bioxcel Therapeutics, Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$1,465
- CAPLYTA$1,096
- ARISTADA$951
- COBENFY$754
- UZEDY$603
- VRAYLAR$372
- INGREZZA$350
- Austedo XR$344
- INVEGA SUSTENNA$260
- Fanapt$250
- ABILIFY MAINTENA$250
- REXULTI$247
- ERZOFRI EXTENDED-RELEASE$246
- ARISTADA INITIO$238
- Auvelity$226
- ABILIFY ASIMTUFII$125
- Zurzuvae$117
- GIAPREZA$113
How this compares
$12,746 in reported general payments places this provider in the 95th percentile of 565 psychiatric/mental health providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 14 | $3,145 |
| Aripiprazole | 29 | $2,435 |
| Paliperidone ErPaliperidone | 19 | $1,911 |
| Haloperidol Decanoate | 16 | $1,371 |
| Clozapine | 19 | $1,080 |
| Quetiapine Fumarate | 37 | $529 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 27 | $500 |
| Olanzapine | 39 | $473 |
| Mirtazapine | 39 | $414 |
| Duloxetine Hcl | 24 | $312 |
| Hydroxyzine Hcl | 13 | $272 |
| Benztropine Mesylate | 19 | $255 |
| Alprazolam | 91 | $248 |
| Bupropion XlBupropion Hcl | 16 | $245 |
| Doxepin Hcl | 12 | $194 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Saint Louis
- Aldijana SacicSaint Louis$510K
- Julie WaterburySaint Louis$135K
- Richard YakimoSaint Louis$10K
- Yevgeniya MykhaylevskaSaint Louis$9K
- Anastasia AmiramovaSaint Louis$9K
- Jessica BurichSaint Louis$8K
- Jennifer ArmstrongSaint Louis$8K
- Bonnie HuffSaint Louis$7K
- Jacqueline KirkSaint Louis$6K
- Danielle RoncoSaint Louis$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.